QUOTE AND NEWS
Cellular News  May 25  Comment 
Syniverse and Roshan, Afghanistan's leading telecommunications provider, have been recognized with a Global Telecoms Business (GTB) Innovation Award for advancing the industry's ability to protect operators'...
Cellular News  May 8  Comment 
Syniverse Holdings will report its first quarter 2017 results on May 10, and will host a conference call on May 11, at 11 a.m. ET to discuss the first quarter financial results. Click here for more.
Automotive World  Apr 12  Comment 
Jaguar is broadening the appeal of the new F-TYPE with the introduction of the state-of-the-art four-cylinder Ingenium petrol engine. The award winning F-TYPE family now spans from the entry-level four-cylinder model to Jaguar’s 200mph...
Forbes  Mar 28  Comment 
But when it came to snaking through the Smoky Mountains on the two-lane I-40 freeway, amidst numerous semi-trucks, the F-Type’s precise steering response was very welcome.
Clusterstock  Mar 20  Comment 
The Jaguar F-Type is one of my favorite cars. I like the F-Type so much that I nearly swayed my colleague Matt DeBord into handing the Jag Business Insider's Car of the Year award in 2014 instead of the game-changing Corvette Stingray. Over...
Forbes  Jun 27  Comment 
Jaguar's new product activity has spiked in the past few weeks. The British brand has just unleashed two all-new models, plus an ultra-high-performance version of its seductive F-Type Coupe and Convertible. We drove the latter on the roads and at...
Benzinga  Jun 7  Comment 
Chardan Capital Markets analysts Madhu Kumar and Gbola Amusa kept a Buy rating on Regulus Therapeutics Inc (NASDAQ: RGLS) following the positive top-line data on Hepatitis C virus treatment. The brokerage boosted its price target to $20 from...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki